nach oben

hautnah

Erschienen in:

16.04.2018 | Ästhetische Dermatologie

Anti-Aging-Strategien

Innovative Konzepte für die Entwicklung von Anti-Aging-Dermokosmetika

verfasst von: Prof. Dr. Cornelia M. Keck

Erschienen in: hautnah | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Zusammenfassung

Effektive Anti-Aging-Wirkstoffe können nur dann entwickeltwerden, wenn der Alterungsprozess vollständig verstanden ist. Da dies bis heute noch nicht vollständig der Fall ist, sind derzeit nur solche Wirkstoffe verfügbar, die in bereits verstandene Teilbereiche des Alterungsprozesses eingreifen können. Der Beitrag umreißt die wesentlichen heute bekannten Anti-Aging-Strategien und erläutert, basierend darauf, neue und innovative Konzepte für die Entwicklung von Anti-Aging-Dermokosmetika.

Vorheriger Artikel Behandlungsmöglichkeiten mit Chemical Peeling

Nächster Artikel „Die Flöhe und die Wanzen gehören auch zum Ganzen“ (Johann Wolfgang von Goethe)

Köckritz A (2001) Flüsse aus Quecksilber. Zeit 11(26):3

da Costa JP et al (2016) A synopsis on agingtheories, mechanisms and future prospects. Ageing Res Rev 29:90–112PubMedCrossRefPubMedCentral

Hasworth SB, Cannon ML (2015) Social theories of aging: a review. Dis Mon 61(11):475–479PubMedCrossRef

Avantaggiato A et al (2015) The theories of aging: reactive oxygen species and what else? J Biol Regul Homeost Agents 29(3Suppl 1):156–163PubMed

Lipsky MS, King M (2015) Biological theories of aging. Dis Mon 61(11):460–466PubMedCrossRef

Libertini G (2015) Non-programmed versus programmed aging paradigm. Curr Aging Sci 8(1):56–68PubMedCrossRef

Goldsmith TC (2015) Is the evolutionary programmed/non-programmed aging argument moot? Curr Aging Sci 8(1):41–45PubMedCrossRef

Aledo JC, Blanco JM (2015) Agingisneitherafailure nor an achievement of natural selection. Curr Aging Sci 8(1):4–10PubMedCrossRef

Cohen AA (2016) Complex systems dynamics in aging: new evidence, continuing questions. Biogerontology 17(1):205–220PubMedCrossRef

10.

Sergiev PV, Dontsova OA, Berezkin GV (2015) Theories of aging: an ever-evolving field. Acta Naturae 7(1):9–18PubMedPubMedCentral

11.

Piotrowska A, Bartnik E (2014) The role of reactive oxygen species and mitochondria in aging. Postepy Biochem 60(2):240–247PubMed

12.

Sikora E (2014) Aging and longevity. Postepy Biochem 60(2):125–137PubMed

13.

Liochev SI (2015) Reflections on the theories of aging, of oxidative stress, and of science in general. Is it time to abandon the free radical (oxidative stress) theory of aging? Antioxid Redox Signal 23(3):187–207PubMedCrossRef

14.

Fulop T et al (2014) On the immunological theory of aging. Interdiscip Top Gerontol 39:163–176PubMedCrossRef

15.

Zs-Nagy I (2014) Aging of cell membranes: facts and theories. Interdiscip Top Gerontol 39:62–85PubMedCrossRef

16.

Le Bourg E (2014) Evolutionary theories of aging can explain why we age. Interdiscip Top Gerontol 39:8–23PubMedCrossRef

17.

Park DC, Yeo SG (2013) Aging. Korean J Audiol 17(2):39–44PubMedPubMedCentralCrossRef

18.

Moskalev AA et al (2014) Genetics and epigenetics ofagingandlongevity. Cell Cycle 13(7):1063–1077PubMedPubMedCentralCrossRef

19.

Hardeland R (2013) Melatonin and the theories of aging: a critical appraisal of melatonin’s role in antiaging mechanisms. J Pineal Res 55(4):325–356PubMed

20.

Mao L, Franke J (2013) Hormesis in aging and neurodegeneration – a prodigy awaiting dissection. Int J Mol Sci 14(7):13109–13128PubMedPubMedCentralCrossRef

21.

Xi H et al (2013) Telomere, aging and age-related diseases. Aging Clin Exp Res 25(2):139–146PubMedCrossRef

22.

Gkogkolou P, Bohm M (2012) Advanced glycation end products: key players in skin aging? Dermatoendocrinol 4(3):259–270PubMedPubMedCentralCrossRef

23.

Naito AT, Komuro I (2013) Chronic inflammation andorganismal aging. Clin Calcium 23(1):51–58PubMed

24.

Madden CL, Cloyes KG (2012) The discourse of aging. ANS Adv Nurs Sci 35(3):264–272PubMedCrossRef

25.

Jenny NS (2012) Inflammation in aging: cause, effect, or both? Discov Med 13(73):451–460PubMed

26.

Cefalu CA (2011) Theories and mechanisms of aging. Clin Geriatr Med 27(4):491–506PubMedCrossRef

27.

Weinert BT, Timiras PS (1985) Invited review: theories of aging. J Appl Physiol 95(4):1706–1716CrossRef

28.

Medvedev ZA (1990) An attempt at a rational classification of theories of ageing. Biol Rev Camb Philos Soc 65(3):375–398PubMedCrossRef

29.

Huber J, Buchacher R (2007) Das Ende des Alterns: Bahnbrechende medizinische Möglichkeiten der Verjüngung. Ullstein, Berlin

30.

Stipp D (2010) The youth pill: scientists at the brink of an anti-aging revolution. Penguin Group, Current

31.

Flatt T (2012) A new definition of aging? Front Genet 3:148PubMedPubMedCentralCrossRef

32.

Busse EW (1969) Onemedical school’s approach to teaching problems of the aging. J Am Geriatr Soc 17(3):299–314PubMedCrossRef

33.

Anstey K, Stankov L, Lord S (1993) Primary aging, secondary aging, and intelligence. Psychol Aging 8(4):562–570PubMedCrossRef

34.

Robinson LJ et al (2003) Proteomic analysis of the genetic premature aging disease Hutchinson Gilford progeria syndrome reveals differential protein expression and glycosylation. J Proteome Res 2(5):556–557PubMedCrossRef

35.

Brown WT (1992) Progeria: a human-disease model of accelerated aging. Am J Clin Nutr 55(6 Suppl):S1222–S1224CrossRef

36.

Brown WT, Zebrower M, Kieras FJ (1985) Progeria, a model disease for the study of accelerate daging. Basic Life Sci 35:375–396PubMed

37.

Blancquaert A (1959) Progeria & progeria-like disease. Maandschr Kindergeneeskd 27(5):157–171PubMed

38.

Paglia DE, Walford RL (2005) Atypical hematological response to combined calorie restriction and chronic hypoxia in biosphere 2 crew: a possible link to latent features of hibernation capacity. Habitation (Elmsford) 10(2):79–85CrossRef

39.

Walford RL et al (2002) Calorie restriction in biosphere 2: alterations in physiologic, hematologic, hormonal, andbiochemicalparameters inhumans restricted for a 2-year period. J Gerontol A Biol Sci Med Sci 57(6):B211–B224PubMedCrossRef

40.

Walford RL et al (1999) Physiologic changes in humans subjected to severe, selective calorie restriction for two years in biosphere 2: health, aging, and toxicological perspectives. Toxicol Sci 52(2Suppl):61–65PubMed

41.

Al-Regaiey KA (2016) The effects of calorie restriction on aging: a brief review. Eur Rev Med Pharmacol Sci 20(11):2468–2473PubMed

42.

Zhang N et al (2016) Calorie restriction-induced SIRT6 activation delays aging by suppressing NFkappaB signaling. Cell Cycle 15(7):1009–1018PubMedPubMedCentralCrossRef

43.

Salvatore MF et al (2016) Initiation of calorie restriction in middle-aged male rats attenuates aging-related motoric decline and bradykinesia without increased striatal dopamine. Neurobiol Aging 37:192–207PubMedCrossRef

44.

Trubitsyn AG (2015) The lag of the proliferative aging clock underlies thelifespan-extending effect of calorie restriction. Curr Aging Sci 8(3):220–226PubMedCrossRef

45.

Karunadharma PP et al (2015) Subacute calorie restriction and rapamycin discordantly alter mouse liver proteome homeostasis and reverse aging effects. Aging Cell 14(4):547–557PubMedPubMedCentralCrossRef

46.

Xu C et al (2015) Calorie restriction prevents metabolic aging caused by abnormal SIRT1 function in adipose tissues. Diabetes 64(5):1576–1590PubMedCrossRef

47.

Kim DH et al (2015) The roles of FoxOs in modulation of aging by calorie restriction. Biogerontology 16(1):1–14PubMedCrossRef

48.

Kim DH et al (2014) The essential role of FoxO6 phosphorylation in aging and calorie restriction. Age (Dordr) 36(4):9679CrossRef

49.

Michan S (2014) Calorie restriction and NAD(+)/sirtuin counteract the hallmarks of aging. Front Biosci 19:1300–1319CrossRef

50.

Testa G et al (2014) Calorie restriction and dietary restriction mimetics: a strategy for improving healthy aging and longevity. Curr Pharm Des 20(18):2950–2977PubMedCrossRef

51.

Yamada Y et al (2013) Long-term calorie restriction decreases metabolic cost of movement and prevents decrease of physical activity during aging in rhesus monkeys. Exp Gerontol 48(11):1226–1235PubMedCrossRef

52.

Yan L et al (2013) Calorie restriction can reverse, as well as prevent, aging cardiomyopathy. Age 35(6):2177–2182PubMedPubMedCentralCrossRef

53.

Chung KW et al (2013) Recent advances in calorie restriction research on aging. Exp Gerontol 48(10):1049–1053PubMedCrossRef

54.

Drewnowski A et al (1996) Diet quality and dietary diversity in France: implications for the French paradox. J Am Diet Assoc 96(7):663–669PubMedCrossRef

55.

Burr ML (1995) Explaining the French paradox. J R Soc Health 115(4):217–219PubMedCrossRef

56.

Renaud S, de Lorgeril M (1993) The French paradox: dietary factors and cigarette smoking-related health risks. Ann N Y Acad Sci 686:299–309PubMedCrossRef

57.

Renaud S, de Lorgeril M (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339(8808):1523–1526PubMedCrossRef

58.

Richard JL (1987) Coronary risk factors. The French paradox. Arch Mal Coeur Vaiss 80(SpecNo):17–21PubMed

59.

Yang X, Li X, Ren J (2014) From French paradox to cancer treatment: anti-cancer activities and mechanisms of resveratrol. Anticancer Agents Med Chem 14(6):806–825PubMedCrossRef

60.

Goldfinger TM (2003) Beyond the French paradox: the impact of moderate beverage alcohol and wine consumption in the prevention of cardiovascular disease. Cardiol Clin 21(3):449–457PubMedCrossRef

61.

Yarnell JW, Evans AE (2000) The Mediterranean diet revisited – towards resolving the (French) paradox. QJM 93(12):783–785PubMedCrossRef

62.

Renaud S, Gueguen R (1998) The French paradox and wine drinking. Novartis Found Symp 216:208–217 (discussion217–22,152–8)PubMed

63.

Kapoor VK, Dureja J, Chadha R (2009) Synthetic drugs with anti-ageing effects. Drug Discov Today 14(17–18):899–904PubMedCrossRef

64.

Harman D (1982) Nutritional implications of the free-radical theory of aging. J Am Coll Nutr 1(1):27–34PubMedCrossRef

65.

Harman D (1988) Free radicals in aging. Mol Cell Biochem 84(2):155–161PubMedCrossRef

66.

Harman D (1991) The aging process: major risk factor for disease and death. Proc Natl Acad Sci USA 88(12):5360–5363PubMedPubMedCentralCrossRef

67.

Harman D (1992) Free radical theory of aging. Mutat Res 275(3–6):257–266PubMedCrossRef

68.

Harman D (1992) Free radical theory of aging: history. EXS 62:1–10PubMed

69.

Harman D (1993) Freeradical involvementinaging. Pathophysiology and therapeutic implications. Drugs Aging 3(1):60–80PubMedCrossRef

70.

Harman D (1994) Free-radical theory of aging. Increasing the functional life span. Ann N Y Acad Sci 717:1–15PubMedCrossRef

71.

Harman D (1998) Extending functional life span. Exp Gerontol 33(1–2):95–112PubMedCrossRef

72.

Harman D (1998) Aging and oxidative stress. J Int Fed Clin Chem 10(1):24–27PubMed

73.

Harman D (2000) Alzheimer’s disease: a hypothesis on pathogenesis. J Am Aging Assoc 23(3):147–161PubMedPubMedCentral

74.

Harman D (2000) Antioxidant supplements: effects on disease and aging in the United States population. J Am Aging Assoc 23(1):25–31PubMedPubMedCentral

75.

Harman D (2001) Aging: overview. Ann N Y Acad Sci 928:1–21PubMedCrossRef

76.

Harman D (2003) The free radical theory of aging. Antioxid Redox Signal 5(5):557–561PubMedCrossRef

77.

Harman D (2006) Free radical theory of aging: an update: increasing the functional lifespan. Ann N Y Acad Sci 1067:10–21PubMedCrossRef

78.

Harman D (2009) About „Origin and evolution of the free radical theory of aging: a brief personal history, 1954–2009“. Biogerontology 10(6):783PubMedCrossRef

79.

Lichtenstein AH, Russell RM (2005) Essential nutrients: food or supplements? Where should the emphasis be? JAMA 294(3):351–358PubMedCrossRef

80.

Murphy SP et al (2007) Multivitamin-multimineral supplements’ effect on total nutrient intake. Am J Clin Nutr 85(1):280–284

81.

Penniston KL, Tanumihardjo SA (2003) Vitamin A in dietary supplements and fortified foods: too much of a good thing? J Am Diet Assoc 103(9):1185–1187PubMedCrossRef

82.

Tomada I, Andrade JP (2015) Science based antiageing nutritional recommendations (Chapter 11). In: Neves D (Hrsg) Anti-ageing nutrients: evidence based prevention of age-associated diseases. Wiley, Hoboken, S 365–390

83.

Diamanti-Kandarakis E et al (2017) Mechanisms in endocrinology: aging and anti-aging: a combo-endocrinology overview. Eur J Endocrinol 176(6):R283–R308PubMedCrossRef

84.

Morley JE (2013) Scientific overview of hormone treatment used for rejuvenation. Fertil Steril 99(7):1807–1813PubMedCrossRef

85.

Zdanys KF, Steffens DC (2015) Sleep disturbances in the elderly. Psychiatr Clin North Am 38(4):723–741PubMedCrossRef

86.

Duffy JF, Zitting KM, Chinoy ED (2015) Aging and circadian rhythms. Sleep Med Clin 10(4):423–434PubMedPubMedCentralCrossRef

87.

Manchester LC et al (2015) Melatonin: an ancient molecule that makes oxygen metabolically tolerable. J Pineal Res 59(4):403–419PubMedCrossRef

88.

Ramis MR et al (2015) Protective effects of melatonin and mitochondria-targeted antioxidants against oxidative stress: a review. Curr Med Chem 22(22):2690–2711PubMedCrossRef

89.

Ramis MR et al (2015) Caloric restriction, resveratrol and melatonin: role of SIRT1 and implications for aging and related-diseases. Mech Ageing Dev 146–148:28–41PubMedCrossRef

90.

Karaaslan C, Suzen S (2015) Antioxidant properties of melatonin and its potential action in diseases. Curr Top Med Chem 15(9):894–903PubMedCrossRef

91.

Jenwitheesuk A et al (2014) Melatonin regulates aging and neurodegeneration through energy metabolism, epigenetics, autophagy and circadian rhythm pathways. Int J Mol Sci 15(9):16848–16884PubMedPubMedCentralCrossRef

92.

Sadowska-Bartosz I, Bartosz G (2014) Effect of antioxidants supplementation on aging and longevity. Biomed Res Int. https://doi.org/10.1155/2014/404680 PubMedPubMedCentralCrossRef

93.

Mayo JC et al (2017) Melatonin and sirtuins: a „notso unexpected“ relationship. J Pineal Res. https://doi.org/10.1111/jpi.12391 CrossRefPubMed

94.

Reiter RJ et al (2002) Melatonin, longevity and health in the aged: an assessment. Free Radic Res 36(12):1323–1329PubMedCrossRef

95.

Tanaka Y et al (1999) Effect of metformin on advanced glycation endproduct formation and peripheral nerve function in streptozotocin-induced diabetic rats. Eur J Pharmacol 376(1–2):17–22PubMedCrossRef

96.

Ouslimani N et al (2007) Metformin reduces endothelial cell expression ofboth the receptor for advanced glycation end products and lectin-like oxidizedreceptor 1. Metabolism 56(3):308–313PubMedCrossRef

97.

Beisswenger P, Ruggiero-Lopez D (2003) Metformin inhibition of glycation processes. Diabetes Metab 29(4Pt2):6S95–6103PubMed

98.

Ishibashi Y et al (2013) Metformin inhibits advanced glycation end products (AGEs)-induced growth and VEGF expression in MCF-7 breast cancer cells by suppressing AGEs receptor expression via AMP-activated protein kinase. Horm Metab Res 45(5):387–390PubMed

99.

Carmona JJ, Michan S (2016) Biology of healthy aging and longevity. Rev Invest Clin 68(1):7–16PubMed

100.

Lopez-Lluch G, Navas P (2016) Calorie restriction as an intervention in ageing. J Physiol 594(8):2043–2060PubMedPubMedCentralCrossRef

101.

Santos J et al (2016) Dietary restriction and nutrient balance in aging. Oxid Med Cell Longev. https://doi.org/10.1155/2016/4010357 CrossRefPubMedPubMedCentral

102.

Pavicic T et al. Dermokosmetika gegen Hautalterung – Leitlinie der GD Gesellschaft für Dermopharmazie e. V. http://www.gd-online.de. Zugegriffen: 12. Juni 2017

103.

Ramos-e-Silva M et al (2013) Anti-aging cosmetics: facts and controversies. Clin Dermatol 31(6):750–758PubMedCrossRef

104.

Trommer H, Böttcher R, Neubert RHH (2002) Ascorbinsäure – Ein Vitamin wie Dr. Jekyll und Mr. Hyde. PZ-Pharmazeutische Zeitung – online, 2002. 48. http://www.pharmazeutische-zeitung. de/index.php?id=24758. Zugegriffen: 25. Juli 2017

105.

SteilingH RM (2009) Castiel I. Bioavaialability and skin bio afficacy of Vitamin C and E. In: Tabor A, Blair RM (Hrsg) Nutritional cosmetics: beauty from within. Elsevier ,William Andrew, Amsterdam, S 113–138

106.

Leveque N et al (2002) Decrease in skin ascorbic acid concentration with age. Eur J Dermatol 12(4):XXI–XXIIPubMed

107.

Passi S et al (2002) Lipophilic antioxidants in human sebum and aging. Free Radic Res 36(4):471–477PubMedCrossRef

108.

Vidlarova L et al (2016) Nanocrystals for dermal penetration enhancement –effect of concentration and underlying mechanisms using curcumin as model. Eur J Pharm Biopharm 104:216–225PubMedCrossRef

109.

Romero GB et al (2015) Industrial concentrates of dermal hesperidin smartCrystals®-production, characterization & long-term stability. Int J Pharm 482(1–2):54–60PubMedCrossRef

110.

Al Shaal L, Müller RH, Shegokar R (2010) smartCrystal combination technology – scale up from lab to pilot scale and long term stability. Pharmazie 65(12):877–884PubMed

111.

Keck CM, Müller RH (2008) Nanodiamanten – Erhöhte Bioaktivität. Labor More 1:64–65

112.

Keck CM, Chen R, Müller RH (2013) SmartCrystals for consumer care & cosmetics: enhanced dermal delivery of poorly soluble plant actives. Househ Pers Care Today 8(5):18–24

113.

Ganceviciene R et al (2012) Skin anti-aging strategies. Dermatoendocrinol 4(3):308–319PubMedPubMedCentralCrossRef

114.

Sparavigna A, Tenconi B, De Ponti I (2015) Antiaging, photoprotective, and brightening activity in biorevitalization: a new solution for aging skin. Clin Cosmet Investig Dermatol 8:57–65PubMedPubMedCentralCrossRef

115.

Zastrow L, Lademann J (2016) Light – instead of UV protection: new requirements for skin cancer prevention. Anticancer Res 36(3):1389–1393PubMed

116.

Darvin ME et al (2010) Radical production by infrared A irradiation in human tissue. Skin Pharmacol Physiol 23(1):40–46PubMedCrossRef

117.

Darvin ME et al (2010) Formation of free radicals in human skin during irradiation with infrared light. J Invest Dermatol 130(2):629–631PubMedCrossRef

118.

Zastrow L et al (2009) UV, visible and infrared light. Which wavelengths produce oxidative stress in human skin? Hautarzt 60(4):310–317PubMedCrossRef

119.

Zastrow L et al (2009) The missing link – light induced (280–1,600 nm) free radical formation in human skin. Skin Pharmacol Physiol 22(1):31–44PubMedCrossRef

120.

Puri P et al (2017) Effects of air pollution on the skin: a review. Indian J Dermatol Venereol Leprol 83(4):415–423PubMedCrossRef

121.

Krutmann J et al (2017) The skin aging exposome. J Dermatol Sci 85(3):152–161PubMedCrossRef

122.

Kim KE, Cho D, Park HJ (2016) Air pollution and skin diseases: adverse effects of airborne particulate matter on various skin diseases. Life Sci 152:126–134PubMedCrossRef

123.

Krutmann J et al (2016) Environmentally induced (extrinsic) skinaging. Hautarzt 67(2):99–102PubMedCrossRef

124.

Li M et al (2015) Epidemiological evidence that indoor air pollution from cooking with solid fuels accelerates skin aging in Chinese women. J Dermatol Sci 79(2):148–154PubMedCrossRef

125.

Pan TL et al (2015) The impact of urban particulate pollution on skin barrier function and the subsequent drug absorption. J Dermatol Sci 78(1):51–60PubMedCrossRef

126.

Hsu S (2015) Compounds derived from Epigallocatechin-3-Gallate (EGCG) as a novel approach to the prevention of viral infections. Inflamm Allergy Drug Targets 14(1):13–18PubMedCrossRef

127.

Kong HH, Segre JA (2017) The molecular revolution in cutaneous biology: investigating the skin microbiome. J Invest Dermatol 137(5):e119–e122PubMedCrossRef

128.

Kirker KR, James GA (2017) In vitro studies evaluating the effects of biofilms on woundhealing cells: a review. APMIS 125(4):344–352PubMedCrossRef

129.

Igawa S, Di Nardo A (2017) Skin microbiome and mast cells. Trans L Res 184:68–76CrossRef

130.

Dreno B et al (2016) Microbiome in healthy skin, update for dermatologists. J Eur Acad Dermatol Venereol 30(12):2038–2047PubMedCrossRefPubMedCentral

131.

Holmes AD, Steinhoff M (2016) Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics. Exp Dermatol. https://doi.org/10.1111/exd.13143 PubMedCrossRef

132.

Cundell AM (2016) Microbial ecology of the human skin. Microb Ecol. https://doi.org/10.1007/s00248-016-0789-6 PubMedCrossRef

133.

Egert M, Simmering R (2016) The microbiota of the human skin. Adv Exp Med Biol 902:61–81PubMedCrossRef

134.

Fyhrquist N et al (2016) Skin biomes. Curr Allergy Asthma Rep 16(5):40PubMedCrossRef

135.

Zealley B, de Grey AD (2013) Strategies for engineered negligible senescence. Gerontology 59(2):183–189PubMedCrossRef

136.

Kaushik G, Leijten J, Khademhosseini A (2017) Concise review: organ engineering: design, technology, and integration. Stem Cells 35(1):51–60PubMedCrossRef

137.

Husain SR, Ohya Y, Puri RK (2017) Current status and challenges of three-dimensional modeling and printing of tissues and organs. Tissue Eng Part A 23(11–12):471–473PubMedCrossRef

138.

Jakus AE, Rutz AL, Shah RN (2016) Advancing the field of 3D biomaterial printing. Biomed Mater 11(1):14102PubMedCrossRef

139.

Yu B et al (2016) An elastic second skin. Nat Mater 15(8):911–918PubMedCrossRef

Titel: Anti-Aging-Strategien
Innovative Konzepte für die Entwicklung von Anti-Aging-Dermokosmetika
verfasst von: Prof. Dr. Cornelia M. Keck
Publikationsdatum: 16.04.2018
Verlag: Springer Vienna
Erschienen in: hautnah / Ausgabe 2/2018
Print ISSN: 1866-2250
Elektronische ISSN: 2192-6484
DOI: https://doi.org/10.1007/s12326-018-0274-8

Springer Medizin Österreich

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2018

„Die Flöhe und die Wanzen gehören auch zum Ganzen“ (Johann Wolfgang von Goethe)

Wenn Patienten flunkern: Sex trotz Abstinenz?

„Du siehst aber schlecht aus!“: Was das Gesicht verrät

Chronisches Ulkus nach Südostasienreise bei 24‑jährigem Mann

Behandlungsmöglichkeiten mit Chemical Peeling

Was wird aus „gesunder Bräune“ in 25 Jahren?